Deutsche Bank’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.1M Sell
1,871,228
-1,492,411
-44% -$27.2M 0.01% 683
2025
Q1
$66.7M Sell
3,363,639
-512,069
-13% -$10.2M 0.03% 541
2024
Q4
$66.5M Sell
3,875,708
-256,311
-6% -$4.4M 0.03% 567
2024
Q3
$82.6M Buy
4,132,019
+1,087,844
+36% +$21.7M 0.03% 464
2024
Q2
$34M Sell
3,044,175
-8,269
-0.3% -$92.4K 0.02% 655
2024
Q1
$20.1M Sell
3,052,444
-2,872
-0.1% -$19K 0.01% 810
2023
Q4
$13.8M Buy
3,055,316
+2,947,382
+2,731% +$13.3M 0.01% 890
2023
Q3
$386K Buy
107,934
+24,696
+30% +$88.4K ﹤0.01% 2309
2023
Q2
$307K Sell
83,238
-48,418
-37% -$179K ﹤0.01% 2640
2023
Q1
$436K Sell
131,656
-40,595
-24% -$134K ﹤0.01% 2575
2022
Q4
$668K Buy
172,251
+8,910
+5% +$34.6K ﹤0.01% 2288
2022
Q3
$397K Sell
163,341
-12,419
-7% -$30.2K ﹤0.01% 2498
2022
Q2
$348K Buy
175,760
+90,360
+106% +$179K ﹤0.01% 2804
2022
Q1
$156K Hold
85,400
﹤0.01% 3363
2021
Q4
$120K Hold
85,400
﹤0.01% 3571
2021
Q3
$97K Hold
85,400
﹤0.01% 3840
2021
Q2
$137K Sell
85,400
-43,844
-34% -$70.3K ﹤0.01% 3933
2021
Q1
$227K Sell
129,244
-1,249
-1% -$2.19K ﹤0.01% 3538
2020
Q4
$255K Sell
130,493
-48,045
-27% -$93.9K ﹤0.01% 3291
2020
Q3
$427K Sell
178,538
-224,641
-56% -$537K ﹤0.01% 2727
2020
Q2
$1.18M Buy
403,179
+293,196
+267% +$859K ﹤0.01% 2105
2020
Q1
$317K Buy
109,983
+5,492
+5% +$15.8K ﹤0.01% 2701
2019
Q4
$417K Buy
104,491
+3,441
+3% +$13.7K ﹤0.01% 2793
2019
Q3
$448K Buy
101,050
+64,879
+179% +$288K ﹤0.01% 2712
2019
Q2
$139K Buy
36,171
+11,885
+49% +$45.7K ﹤0.01% 3935
2019
Q1
$91K Sell
24,286
-845
-3% -$3.17K ﹤0.01% 4194
2018
Q4
$59K Sell
25,131
-85,878
-77% -$202K ﹤0.01% 4202
2018
Q3
$689K Buy
111,009
+74,711
+206% +$464K ﹤0.01% 3533
2018
Q2
$163K Buy
+36,298
New +$163K ﹤0.01% 4224
2016
Q3
Sell
-4,684
Closed -$27K 4418
2016
Q2
$27K Buy
4,684
+484
+12% +$2.79K ﹤0.01% 4345
2016
Q1
$33K Buy
+4,200
New +$33K ﹤0.01% 4182
2015
Q3
Sell
-1,200
Closed -$11K 4652
2015
Q2
$11K Buy
+1,200
New +$11K ﹤0.01% 4576